US EditionBleeding Risk of Anticoagulants Decreases Over Time
Summary by Kalstein
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Bleeding Risk of Anticoagulants Decreases Over Time
Anticoagulant therapy, commonly prescribed for the treatment of venous thromboembolism (VTE), presents a bleeding risk that varies over time. This risk is most concerning during the first six months of treatment, after which it significantly decreases, potentially affecting the benefit-risk ratio. Understanding Venous Thromboembolism and Anticoagulant Therapy Venous thromboembolism (VTE) requires urgent and sometimes prolonged anticoagulant trea…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
